Search Results
Found 1 results
510(k) Data Aggregation
(150 days)
SLEEPAPP
The SLEEPAPPADV is intended for the management of snoring and mild to moderate obstructive sleep apnea in adults 18 years of age and older.
Not Found
This FDA letter for K182202, a 510(k) premarket notification for the SLEEPAPPADV™ device, does not contain information regarding detailed acceptance criteria, specific study designs, or performance metrics. It primarily confirms the device's substantial equivalence to a predicate device and outlines general regulatory obligations.
Therefore, I cannot provide the requested information, including the table of acceptance criteria and device performance, sample sizes, data provenance, expert details, adjudication methods, MRMC study results, standalone performance, ground truth types, or training set details. This information is typically found in the 510(k) summary or the full submission, which is not provided in the given text.
Ask a specific question about this device
Page 1 of 1